内皮脂酶变体T111I不会改变血管类蛋白质的抑制作用
Kelli L Sylvers-Davie1,2, Kaleb C Bierstedt1,3, Michael J Schnieders1,3
1Department of Biochemistry and Molecular Biology, University of Iowa, 169 Newton Rd., PBDB 3326, Iowa, IA, 52242, USA.
Scientific reports
|February 21, 2024
概括
内皮脂酶 (EL) 基因中的遗传变异不会改变EL酶的功能或由ANGPTL蛋白抑制其功能. 这些发现表明这种变体是变体.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 心血管疾病研究研究
背景情况:
- 高密度脂蛋白胆固醇 (HDL-C) 与降低心血管疾病风险有关.
- 内皮脂酶 (EL) 水解高密度脂肪酸脂,降低高密度脂肪酸-C.
- 一种常见的LIPG基因多态 (584C/T) 导致T111I EL蛋白变体,与HDL水平和冠状动脉疾病 (CAD) 有不一致的联系.
研究的目的:
- 生物化学研究EL T111I变异对EL酶活性,结构和稳定性的影响.
- 为了确定T111I变异是否影响血管蛋白样3 (ANGPTL3) 和血管蛋白样4 (ANGPTL4) 的EL抑制.
主要方法:
- 生物化学测试以评估EL酶活性.
- 蛋白质稳定性和结构完整性的分析.
- 使用纯化的EL变体和ANGPTL3/ANGPTL4蛋白质进行抑制试验.
主要成果:
- 该EL T111I变体没有改变EL酶活性或蛋白质稳定性.
- 没有观察到由ANGPTL3和ANGPTL4.4抑制野生类型EL与T111IEL的显著差异.
- 这种T111I变异似乎不会影响EL与关键调节蛋白的相互作用.
结论:
- T111I EL变体对高血糖水平和心血管疾病风险的影响不太可能由改变的EL酶功能或ANGPTL抑制介导.
- 需要进一步的研究来阐明这种遗传变异影响心血管健康的机制,如果有的话.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
165
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
165
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
638
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
638


